Tuesday, April 29, 2025
29.9 C
Bengaluru

National Seminar on UCPMP

National Seminar on Uniform Code of Pharmaceutical Marketing Practices (UCPMP) - Karnataka Drug and Pharmaceutical Producers Association (KDPMA)

Theme: “Building Brands – Building a Future”

Friday, 16 September 2016 | Hotel Lalit Ashok, Kumara Krupa Road, Bangalore (Google Maps)


Seminar Objectives

The seminar will help companies especially Product Management Teams and Sales Teams to understand their changing roles due to UCPMP. It will also bring clarity on strategies and promotional inputs including CME’s, sampling, gifts etc. Part of deliberation will also cover monitoring and implementation of UCPMP. The eminent speakers will also share their perspective on the future of brand building in the post-UCPMP era.


Keynote Speaker

  • Shri. Sudhansh Pant, IAS – Joint Secretary, Dept. of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India

Speakers

  • Dr. Ganesh Nayak – Executive Director and CEO, Zydus Cadila Ltd.
  • Anup Soans – Editor, MedicinMan
  • Samir Rai – National Sales Manager, Meyer Organics (Sales and Marketing, in charge of 4 divisions.)
  • Dr. H. N. Ravindra – Executive Committee Member, Indian Medical Council, New Delhi

Registration

Download the registration form below and mail to the address mentioned within.

[wpfilebase tag=file id=81 tpl=thumbnail target=blank/]

 

 

 

Hot this week

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Topics

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Indian Pharma Market (IPM) Highlights – January 2025

Overall IPM Performance: Monthly Growth: IPM monthly growth reached 8.4% in...

Role of AI Across Pharma Industry

Introduction Artificial intelligence (AI) is increasingly pivotal in driving innovation...
spot_img

Related Articles

spot_imgspot_img